Advanced company searchLink opens in new window

AMRYT PHARMA LIMITED

Company number 12107859

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
18 Aug 2021 AP01 Appointment of Dr. Roni Mamluk as a director on 5 August 2021
18 Aug 2021 AP01 Appointment of Mr Rajkumar Kannan as a director on 5 August 2021
18 Aug 2021 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES13 ‐ Re-authorised to make market purchases/receive & adopt financial statements 28/07/2021
  • RES10 ‐ Resolution of allotment of securities
05 Aug 2021 AD03 Register(s) moved to registered inspection location Central Square 29 Wellington Street Leeds LS1 4DL
05 Aug 2021 AD02 Register inspection address has been changed to Central Square 29 Wellington Street Leeds LS1 4DL
30 Jul 2021 CS01 Confirmation statement made on 16 July 2021 with no updates
13 Jul 2021 AA Full accounts made up to 31 July 2020
13 Nov 2020 SH04 Sale or transfer of treasury shares. Treasury capital:
  • GBP 287,502.18
20 Oct 2020 CS01 Confirmation statement made on 16 July 2020 with updates
19 Aug 2020 RESOLUTIONS Resolutions
  • RES13 ‐ To receive audited financial statements and directors reports / reappoint auditors / us sub-plan adopted 29/07/2020
  • RES10 ‐ Resolution of allotment of securities
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES09 ‐ Resolution of authority to purchase a number of shares
  • RES01 ‐ Resolution of adoption of Articles of Association
18 Aug 2020 MA Memorandum and Articles of Association
10 Dec 2019 SH02 Statement of capital on 7 November 2019
  • GBP 9,463,106.28
10 Dec 2019 SH03 Purchase of own shares. Shares purchased into treasury:
  • GBP 291,879.36
19 Nov 2019 PSC08 Notification of a person with significant control statement
19 Nov 2019 PSC07 Cessation of John Mcevoy as a person with significant control on 24 September 2019
14 Nov 2019 SH01 Statement of capital following an allotment of shares on 24 September 2019
  • GBP 9,513,106.22
05 Nov 2019 SH19 Statement of capital on 5 November 2019
  • GBP 9,513,106.22
05 Nov 2019 CERT21 Certificate of cancellation of share premium account
05 Nov 2019 OC138 Reduction of iss capital and minute (oc)
11 Oct 2019 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES13 ‐ Adopt shar optionplan / approve waiver/ authority to make market purchases 23/09/2019
  • RES01 ‐ Resolution of adoption of Articles of Association
  • RES10 ‐ Resolution of allotment of securities
03 Oct 2019 AP01 Appointment of Dr Patrick Volkert Jozef Joihannes Vink as a director on 24 September 2019
01 Oct 2019 TM01 Termination of appointment of John Mcevoy as a director on 24 September 2019
01 Oct 2019 TM01 Termination of appointment of Rory Peter Nealon as a director on 24 September 2019
01 Oct 2019 AP01 Appointment of Mr Stephen Wills as a director on 24 September 2019
01 Oct 2019 AP01 Appointment of Mr Donald Kenneth Stern as a director on 24 September 2019